A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2004
12/29/2004	WO2004089334A3 Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
12/29/2004	WO2004084949A3 Generating protein pro-drugs using reversible ppg linkages
12/29/2004	WO2004082640A3 Human serum albumin conjugates with therapeutic compounds
12/29/2004	WO2004080415A3 Gel composition and method for treatment of vaginal infections
12/29/2004	WO2004078926A3 Immunologigal markers
12/29/2004	WO2004078097A3 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer
12/29/2004	WO2003049699A3 Novel monofunctional polyethylene glycol aldehydes
12/29/2004	WO2003035790A9 Improved method for generating an aerosol
12/29/2004	EP1491554A1 PEGylated soluble gp130-dimers useful as a medicament
12/29/2004	EP1491236A1 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
12/29/2004	EP1491217A1 Stabilization of polynucleotide complexes
12/29/2004	EP1491215A1 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like
12/29/2004	EP1491214A1 Drugs for treating liver diseases with the use of hollow protein nanoparticles
12/29/2004	EP1491210A1 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles
12/29/2004	EP1491208A1 Stabilized liquid polypeptide-containing pharmaceutical compositions
12/29/2004	EP1491204A1 Process for producing fat composition containing hydrophobic components of glycyrrhiza
12/29/2004	EP1491202A1 Nail restructuring compositions for topical application
12/29/2004	EP1491193A1 Therapeutic combinations comprising amlodipine and atorvastatin
12/29/2004	EP1491189A1 Diclofenac sodium oral pharmaceutical
12/29/2004	EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/29/2004	EP1490121A1 Drug delivery particle
12/29/2004	EP1490119A1 Tissue treatment
12/29/2004	EP1490110A2 Anti-alpha v beta 6 antibodies
12/29/2004	EP1490109A2 Egfr ligands and methods of use
12/29/2004	EP1490103A2 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthama(obstructive lung disease)
12/29/2004	EP1490095A1 Stable pharmaceutical composition containing factor viii
12/29/2004	EP1490090A2 Active agent delivery systems and methods for protecting and administering active agents
12/29/2004	EP1490089A1 Peptides selectively lethal to malignant and transformed mammalian cells
12/29/2004	EP1490078A1 Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytochrome p-450
12/29/2004	EP1490068A1 Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
12/29/2004	EP1490038A1 Hybrid system for solubilizing pharmaceutically active substances in polymer matrices
12/29/2004	EP1490037A1 Taste masked veterinary solid compositions
12/29/2004	EP1490036A1 Sustained release formulation of tramadol
12/29/2004	EP1490035A1 Intraorally disintegrating valdecoxib compositions
12/29/2004	EP1490033A1 No-donating nsaids adsorbed into carrier particles
12/29/2004	EP1490031A1 Fast melt multiparticulate formulations for oral delivery
12/29/2004	EP1490030A1 Nanoparticulate compositions of angiogenesis inhibitors
12/29/2004	EP1490027A1 Methods for entrapment of bioactive agent in a liposome or lipid complex
12/29/2004	EP1490025A2 Nanoparticulate compositions of map kinase inhibitors
12/29/2004	EP1489988A1 Dispensing apparatus and cartridge
12/29/2004	EP1489924A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
12/29/2004	EP1489916A1 A low fat cocoa extract
12/29/2004	EP1439818B1 Chewable tablet containing lysine
12/29/2004	EP1379220B1 Inhalation capsules
12/29/2004	EP1357928A4 A novel pharmaceutical compound and methods of making and using same
12/29/2004	EP1289562B1 Novel preparation of hypericin bonded with poly-n-vinylamides
12/29/2004	EP1259114B1 A topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
12/29/2004	EP1244657B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/29/2004	EP1225902B1 Ciclesonide contained pharmaceutical composition for application to mucosa
12/29/2004	EP1216048B1 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols
12/29/2004	EP1210069B1 Large porous particles obtainable by spray-drying and suitable for pulmonary administration
12/29/2004	EP1163209A4 Compounds and compositions for delivering active agents
12/29/2004	EP1161456B1 Ccr5 binding antibody constructs and their use for treating autoimmune diseases
12/29/2004	EP1146959A4 Method and apparatus for liposome production
12/29/2004	EP1124576B1 Method for preparing solid phase conjugate vaccines
12/29/2004	EP1096937B1 Sustained release ranolazine formulations
12/29/2004	EP1028757B1 Radioactive embolizing compositions
12/29/2004	EP1011728B1 Polypropylene containers for prostaglandin products
12/29/2004	EP0981332B1 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
12/29/2004	EP0947244B1 Solubilizers, emulsifiers and dispersants
12/29/2004	EP0935651B1 THERAPY FOR alpha-GALACTOSIDASE A DEFICIENCY
12/29/2004	EP0910390B1 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
12/29/2004	CN1558952A Pegylated and diglycosylated erythropoietin
12/29/2004	CN1558915A Leukocyte inactivation module
12/29/2004	CN1558900A Pseudopolymorphic forms of carvedilol
12/29/2004	CN1558777A An antineoplastic dendritic polymer drug delivery system
12/29/2004	CN1558776A Solid composition containing bacillus-type non-pathogenic bacterial spores
12/29/2004	CN1558775A Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/29/2004	CN1558774A Angiotensin peptide-carrier conjugates and uses thereof
12/29/2004	CN1558773A Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of vibrio cholerae O139 bound to tetanus toxoid
12/29/2004	CN1558755A Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
12/29/2004	CN1558754A Pharmaceutical dosage form with multiple coatings
12/29/2004	CN1558752A Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn disease
12/29/2004	CN1558751A Method and composition for dry eye treatment
12/29/2004	CN1558749A Oral composition for treating sensitive teeth
12/29/2004	CN1557495A Intelligent medicine release system and its preparation and usage
12/29/2004	CN1557479A Interferon liposome emulsifiable paste
12/29/2004	CN1557335A Externally used combined stabilizer of sodium percarbonate
12/29/2004	CN1557327A Adefovir dipivoxil and polyethylene glycol fused matter and its preparation method
12/29/2004	CN1557282A Modified water-soluble medicine and vaccine embedded macromolecule microsphere preparation method
12/29/2004	CN1182395C Nanoparticles with polymer shells
12/29/2004	CN1182219C Process for preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
12/29/2004	CN1181826C Lipid-based immune regulator composition
12/29/2004	CN1181816C Swelling and deswelling polymer blends
12/29/2004	CN1181815C Pharmaceutical preparation
12/29/2004	CN1181814C Fast oral dissolving films containing an ion exchange resin as a taste masking agent
12/29/2004	CN1181738C Therapeutic anti-fungal nail preparation
12/29/2004	CA2839930A1 Ophthalmic compositions containing a synergistic combination of two polymers
12/29/2004	CA2839928A1 Ophthalmic compositions containing a synergistic combination of two polymers
12/29/2004	CA2839898A1 Ophthalmic compositions containing a synergistic combination of two polymers
12/29/2004	CA2839849A1 Ophthalmic compositions containing a synergistic combination of two polymers
12/29/2004	CA2839847A1 Ophthalmic compositions containing a synergistic combination of two polymers
12/29/2004	CA2540695A1 Specific delivery of drugs to the brain
12/29/2004	CA2530736A1 Pharmaceutical compositions comprising ph-sensitive block copolymers and a hydrophobic drug
12/29/2004	CA2530003A1 Drug delivery device comprising an active compound and method for releasing an active compound from a drug delivery device
12/29/2004	CA2529860A1 Ophthalmic composition
12/29/2004	CA2529503A1 Drug polymer complexes
12/29/2004	CA2528313A1 Nail restructuring compositions for topical application
12/29/2004	CA2527712A1 Ophthalmic compositions containing a synergistic combination of two polymers
12/29/2004	CA2526642A1 Compositions in the form of a spray comprising a pharmaceutical agent at least one volatile silicone and a non-volatile oily phase

1 ... 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 ... 1712